情绪障碍 - Suppr | 超能文献

情绪障碍 - Suppr | 超能文献

相似文献

1

Mood disorders.情绪障碍

Am Fam Physician. 1984 Dec;30(6):99, 102.

2

Consensus development summaries. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health.共识发展总结。情绪障碍：复发的药物预防。美国国立卫生研究院。

Conn Med. 1985 Mar;49(3):157-63.

3

Lithium in treatment and prevention of affective disorder. A VA-NIMH collaborative study.锂盐在情感障碍治疗与预防中的应用。一项退伍军人事务部-美国国立精神卫生研究所合作研究。

Dis Nerv Syst. 1974 Jul;35(7):327-33.

4

5-Hydroxytryptamine in the pathogenesis of affective disorders.5-羟色胺在情感障碍发病机制中的作用

Adv Biochem Psychopharmacol. 1982;34:249-58.

5

NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel.美国国立精神卫生研究所/美国国立卫生研究院共识发展会议声明。情绪障碍：复发的药物预防。共识发展小组。

Am J Psychiatry. 1985 Apr;142(4):469-76. doi: 10.1176/ajp.142.4.469.

6

Mood disorders: pharmacologic prevention of recurrences. A National Institutes of Health consensus report synopsis.情绪障碍：复发的药物预防。国立卫生研究院共识报告概要。

Indiana Med. 1985 Jan;78(1):36-7.

7

[Lithium and other preventive agents of affective disorders in 1983].[1983年的锂及其他情感障碍预防剂]

Cesk Psychiatr. 1984 Aug;80(4):247-51.

8

Prophylactic lithium treatment: treatment response, and patient attitudes toward illness and treatment.

Pharmacopsychiatry. 1988 Nov;21(6):274-5. doi: 10.1055/s-2007-1016973.

9

Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.血清素转运体基因与心境障碍锂盐预防性治疗之间可能存在关联的进一步证据。

Pharmacogenomics J. 2004;4(4):267-73. doi: 10.1038/sj.tpj.6500252.

10

Lithium in the prophylactic treatment of recurrent affective disorders.

Singapore Med J. 1982 Oct;23(5):262-4.